drugset / Trial / NCT00229216

Treatment of Bacterial Vaginosis With Oral Tinidazole

NCT00229216

Phase 3 Completed 200 enrolled Mission Pharmacal
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.

Timeline

Start
2005-01
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject tinidazole Small molecule 1 g Oral
Subject tinidazole Small molecule 2 g Oral

Indications